Neil Woodford’s Latest Buys and Sells: GlaxoSmithKline plc (ADR) (GSK), AstraZeneca plc (ADR) (AZN)

Page 1 of 2

LONDON — It’s always useful to see which shares the experts are buying, especially in times as uncertain as these.

Neil Woodford is as expert as they come. Through his Invesco Perpetual Income and High Income Funds, he looks after more than 22 billion pounds of client money. His High Income Fund has generated a superb 342% return over the last 15 years — outperforming the FTSE All-Share index by more than 200%.

GlaxoSmithKline PurchaseSo, what has Woodford been buying and selling? Well, the latest annual report for his 12.5 billion pound High Income Fund has just been published, and the document reveals which stocks he’s been pumping cash into and which stocks he’s been cutting back on or disposing of completely.

Security guards wanted
Woodford’s biggest company purchase from within the FTSE 100 during the period was global security group G4S plc (LON:GFS). The maestro’s timing wasn’t great on this one as he began buying before the company’s Olympic Games debacle.

However, he has since averaged down with a vengeance, bringing his total investment to over 200 million pounds. According to my calculations, his average buy price was 260 pence.

The shares have recovered nicely and are currently trading at around 290 pence, or 11.5 times forecast 2013 earnings. The earnings multiple is below the FTSE average, while a forward dividend yield of 3.2% is about in line with the market.

Hipster and hooked on drugs
Woodford’s second-largest buy from among the U.K.’s blue chips was Smith & Nephew plc (ADR) (NYSE:SNN) . The company, which makes hip-replacement and other medical devices, attracted a 175 million pound investment from Woodford.

My sums tell me he paid an average price of 632 pence for this stock, which is currently changing hands for more than 700 pence. The forward price-to-earnings (P/E) ratio of over 14 appears to be a fair rather than bargain rating, while the dividend yield is a subpar 2.3%.

Health care in general, but big pharma in particular, continues to be Woodford’s most heavily backed sector. He has been a net buyer of Europe’s five drugs giants.

The U.K.’s big two, GlaxoSmithKline plc (ADR) (NYSE:GSK) and AstraZeneca plc (ADR) (NYSE:AZN), saw continued inflows, along with France’s Sanofi and Swiss groups Roche and Novartis. Woodford dug deepest into the coffers for the last named, investing around 225 million.

Not ringing Woodford’s bell
Following his much-discussed disposal of all the fund’s shares in Tesco Corporation (USA) (NASDAQ:TESO) at the start of last year, Woodford’s biggest sale since has been Vodafone Group plc (LON:VOD) .

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!